MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin

scientific article published on 22 July 2013

MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CNS.12149
P932PMC publication ID6493457
P698PubMed publication ID23870455
P5875ResearchGate publication ID250922118

P50authorLing-Zhi LiuQ59680831
Bing-Hua JiangQ63561312
P2093author name stringLin Wang
Peng Zhao
Wei Li
Bing-Hua Jiang
Ling-Zhi Liu
Min Wang
Ning Liu
Qing Xu
Xu Qian
Zhu-Mei Shi
P2860cites workProhibitin Induces the Transcriptional Activity of p53 and Is Exported from the Nucleus upon Apoptotic SignalingQ24294918
Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanismQ24297530
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1Q24316075
Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repressionQ24323389
Real-time quantification of microRNAs by stem-loop RT-PCRQ24535510
MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb proteinQ24601263
Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathwaysQ24624119
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancersQ24625794
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer modelQ24655262
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivoQ24657924
Oncomirs - microRNAs with a role in cancerQ27860773
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomaQ27860910
Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell linesQ37696405
The role of prohibitin in cell signaling.Q37788816
MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.Q38336556
Insulin induced phosphorylation of prohibitin at tyrosine 114 recruits Shp1.Q38353489
MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth.Q39329358
Gliomas display a microRNA expression profile reminiscent of neural precursor cells.Q39712696
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitinQ39940332
Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cellsQ40236424
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migrationQ40393756
Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cellsQ42813169
Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signalingQ42832815
A PCR-based platform for microRNA expression profiling studiesQ43155279
Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis.Q53450181
Differential protein expression in human gliomas and molecular insights.Q55471500
MicroRNA signatures in human cancersQ27860962
MicroRNAs: genomics, biogenesis, mechanism, and functionQ27861070
Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins.Q27934000
The Prohibitins: emerging roles in diverse functionsQ28248077
The diverse functions of microRNAs in animal development and diseaseQ28266193
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastomaQ28280337
Ras-Raf signaling needs prohibitinQ28282450
MYC stimulates EZH2 expression by repression of its negative regulator miR-26aQ28291303
Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancerQ28295895
MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2Q28302211
Phylogenetic shadowing and computational identification of human microRNA genesQ28302536
Ribo-gnome: the big world of small RNAsQ29615681
Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responsesQ30448411
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trialQ33453675
Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity.Q33574529
Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cellsQ33664289
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorshipQ33719798
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM.Q33853600
miR-182 as a prognostic marker for glioma progression and patient survival.Q33947151
miR-34a regulates mouse neural stem cell differentiationQ33998797
Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death geneQ34017894
Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiformeQ34207182
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaQ34216713
Malignant glioma: genetics and biology of a grave matter.Q34272357
Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in miceQ34420616
The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative diseaseQ34536917
MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expressionQ34841931
Proteomics of gliomas: initial biomarker discovery and evolution of technologyQ35170365
MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesisQ35672212
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancerQ36070061
Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescenceQ36404944
AKT signaling in regulating angiogenesisQ37089915
Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signalingQ37146258
Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expressionQ37220420
P433issue10
P921main subjectmicroRNAQ310899
P304page(s)804-812
P577publication date2013-07-22
P1433published inCNS Neuroscience & TherapeuticsQ5013184
P1476titleMicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin
P478volume19

Reverse relations

cites work (P2860)
Q28269042A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation
Q46923795Association of prohibitin-1 and 2 with oxidative stress in rats with renal interstitial fibrosis
Q60929868Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells
Q91973832Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas
Q92617953Diagnostic value of a microRNA signature panel in exosomes for patients with hepatocellular carcinoma
Q64077453Differentiation antagonizing non-protein coding RNA modulates the proliferation, migration, and angiogenesis of glioma cells by targeting the miR-216a/LGR5 axis and the PI3K/AKT signaling pathway
Q90700351Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
Q64052645Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma
Q34982573Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4.
Q36561540MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells
Q60111042MicroRNA dysregulation in lung injury: the role of the miR-26a/EphA2 axis in regulation of endothelial permeability
Q49790324MicroRNA-26a and Tumor
Q54094778MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer.
Q42290877MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia
Q28087391Multifaceted role of prohibitin in cell survival and apoptosis
Q60927782Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme
Q89797048Prohibitin 1 in liver injury and cancer
Q36797902Role of MicroRNAs in Malignant Glioma
Q55253157Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.
Q98386355Small RNA profiles of HTLV-1 asymptomatic carriers with monoclonal and polyclonal rearrangement of the T-cell antigen receptor γ-chain using massively parallel sequencing: A pilot study
Q38796729The role of microRNA-26a in human cancer progression and clinical application
Q38862889Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression

Search more.